Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Periodontal pathogens refer to a diverse group of predominantly anaerobic bacteria that colonize the subgingival environment and are the primary etiological agents of periodontal disease (NIH NIDCR). Key species include the 'red complex' organisms—Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola—which are known for their high virulence and association with clinical attachment loss (Socransky et al., 1998). These bacteria form complex, multi-species biofilms that provide protection against host immune defenses and antimicrobial agents (Hajishengallis, 2015). The 'phenotypic combination effect' describes the synergistic or additive outcomes observed when these pathogens are treated with combinations of drugs, such as the 'van Winkelhoff cocktail' of amoxicillin and metronidazole (van Winkelhoff et al., 1989). Therapeutic interventions aim to reduce the microbial load and disrupt biofilm architecture to halt the inflammatory destruction of the periodontium and prevent tooth loss (Pihlstrom et al., 2005).
Antimicrobial agents target periodontal pathogens by inhibiting cell wall synthesis, protein synthesis, or DNA replication. Combination therapies often exhibit synergistic effects by targeting different bacterial species within the biofilm or overcoming resistance mechanisms.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Periodontal pathogens.